Antidiabetogenic action of cholecystokinin in type 2 diabetes
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Antidiabetogenic action of cholecystokinin in type 2 diabetes. / Ahrén, Bo; Holst, J.J.; Efendic, S.
In: J. Clin. Endocrinol. Metab., No. 85, 2000, p. 1043-8.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Ahrén, B, Holst, JJ & Efendic, S 2000, 'Antidiabetogenic action of cholecystokinin in type 2 diabetes', J. Clin. Endocrinol. Metab., no. 85, pp. 1043-8.
APA
Ahrén, B., Holst, J. J., & Efendic, S. (2000). Antidiabetogenic action of cholecystokinin in type 2 diabetes. J. Clin. Endocrinol. Metab., (85), 1043-8.
Vancouver
Ahrén B, Holst JJ, Efendic S. Antidiabetogenic action of cholecystokinin in type 2 diabetes. J. Clin. Endocrinol. Metab. 2000;(85):1043-8.
Author
Bibtex
@article{fa0299f074c711dbbee902004c4f4f50,
title = "Antidiabetogenic action of cholecystokinin in type 2 diabetes",
author = "Bo Ahr{\'e}n and J.J. Holst and S. Efendic",
year = "2000",
language = "English",
pages = "1043--8",
journal = "J. Clin. Endocrinol. Metab.",
number = "85",
}
RIS
TY - JOUR
T1 - Antidiabetogenic action of cholecystokinin in type 2 diabetes
AU - Ahrén, Bo
AU - Holst, J.J.
AU - Efendic, S.
PY - 2000
Y1 - 2000
M3 - Journal article
SP - 1043
EP - 1048
JO - J. Clin. Endocrinol. Metab.
JF - J. Clin. Endocrinol. Metab.
IS - 85
ER -
ID: 175861